参考文献/References:
[1] SCHELTENS P, DE STROOPER B, KIVIPELTO M, et al. Alzheimer’s disease[J]. Lancet (London, England), 2021, 397(10284): 1577-1590.
[2] BHATT J , HERRERA A C , AMICO F D ,et al. The world Alzheimer report 2019: attitudes to dementia[EB/OL]. https://www.researchgate.net/publication/335927874_The_World_Alzheimer_Report_2019_Attitudes_to_dementia.
[3] JAYEDI A, RASHIDY-POUR A, SHAB-BIDAR S. Vitamin D status and risk of dementia and Alzheimer’s disease: a meta-analysis of dose-response[J]. Nutritional Neuroscience, 2019, 22(11): 750-759.
[4] BEATA B K, WOJCIECH J, JOHANNES K, et al. Alzheimer’s disease-biochemical and psychological background for diagnosis and treatment[J]. International Journal of Molecular Sciences, 2023, 24(2): 1059.
[5] CHRISTAKOS S, AJIBADE D V, DHAWAN P, et al.Vitamin D: metabolism[J]. Rheumatic Diseases Clinics of North America, 2012, 38(1): 1-11.
[6] GOLTZMAN D, HENDY G N, WHITE J H. Vitamin D and its receptor during late development[J]. Biochimica et Biophysica Acta, 2015, 1849(2): 171-180.
[7] 陈旺,孙茜,刘兆鹏．活性维生素D类药物临床研究进展[J].中国新药杂志,2019,28(23):2832-2839. CHEN Wang, SUN Qian, LIU Zhaopeng. Clinical research progress of active vitamin D drugs[J]. Chinese Journal of New Drugs, 2019, 28(23): 2832-2839.
[8] MORETTI R, MORELLI M E, CARUSO P. Vitamin D in neurological diseases: a rationale for a pathogenic impact[J]. International Journal of Molecular Sciences, 2018, 19(8): 2245.
[9] BEHL T, KAUR I, FRATILA O, et al. Exploring the potential of therapeutic agents targeted towards mitigating the events associated with amyloid-β cascade in Alzheimer’s disease[J]. International Journal of Molecular Sciences, 2020, 21(20): 7443.
[10] ONO K, WATANABE-NAKAYAMA T. Aggregation and structure of amyloid β-protein [J]. Neurochemistry International, 2021,151:105208.
[11] LAURENT C, BU?E L, BLUM D. Tau and neuroinfla-mmation:What impact for Alzheimer’s disease and Tauopathies[J]. Biomedical Journal, 2018, 41(1): 21-33.
[12] CIOFFI F, ADAM R H I, BROERSEN K. Molecular mechanisms and genetics of oxidative stress in Alzheimer’s disease[J]. Journal of Alzheimer’s Disease, 2019, 72(4): 981-1017.
[13] FAN Yongang, PANG Zhongqiu, WU Tingyao, et al. Vitamin D deficiency exacerbates Alzheimer-like pathologies by reducing antioxidant capacity [J]. Free Radical Biology and Medicine, 2020, 161:139-149.
[14] JIA Jingya, HU Jing, HUO Xiaoxu, et al. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial[J]. Journal of Neurology, Neurosurgery, and Psychiatry, 2019, 90(12): 1347-1352.
[15] ISRAEL L L，SUN Tao，BRAUBACH O, et al. β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer’s disease mouse models [J]. Journal of Controlled Release, 2023, 361:636-658.
[16] AR?VALO N B, CASTILLO-GODOY D P, ESPINOZA-FUENZALIDA I, et al. Association of vitamin D receptor polymorphisms with amyloid-β transporters expression and risk of mild cognitive impairment in a chilean cohort [J]. Journal Alzheimer’s Disease 2021, 82(s1):S283-S297.
[17] PATEL P, SHAH J. Role of vitamin D in amyloid clearance via LRP-1 upregulation in Alzheimer’s disease: a potential therapeutic target? [J] Journal of Chemical Neuroanatomy, 2017, 85: 36-42.
[18] GUO Y X, HE L Y, ZHANG M, et al. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood e?ux and peripheral uptake transport [J]. Neuroscience, 2016, 322: 28-38.
[19] BERRIDGE M J. Vitamin D and depression：cellular and regulatory mechanisms[J]. Pharmacological Reviews, 2017, 69(2): 80-92.
[20] DURSUN E, GEZEN-AK D, YILMAZER S. A novel perspective for Alzheimer’s disease:vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons[J]. Journal of Alzheimer’s Disease, 2011, 23(2): 207-219.
[21] JI Lili, TONG Lei, PENG Junbo, et al. Changes in the expression of the vitamin D receptor and LVSCC-A1C in the rat hippocampus submitted to single prolonged stress[J]. Molecular Medicine Reports, 2014, 9(4): 1165-1170.
[22] JASSIL N K,SHARMA A,BIKLE D, et al.Vitamin D binding protein and 25-hydroxy vitamin D levels:emerging clinical applications[J]. Endocrine Practice，2017, 23(5): 605-613.
[23] JEON S G,CHA M Y, KIM J I, et al.Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer’s disease-related pathology in 5XFAD mice [J].Nanomedicine: Nanotechnology, Biology and Medicine, 2019, 17: 297-307.
[24] MOON M,SONG H,HONG H J, et al.Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology[J].Cell Death and Differentiation, 2013, 20(4): 630-638.
[25] SATHYA S,SHANMUGANATHAN B, BALASUBRAMA NIAM B, et al. Phytol loaded PLGA nanoparticles regulate the expression of Alzheimer’s related genes and neuronal apoptosis against amyloid-β induced toxicity in Neuro-2a cells and transgenic Caenorhabditis elegans [J]. Food and Chemical Toxicology, 2020, 136: 110962.
[26] LIU Junlin, FAN Yonggang, YANG Zhengsheng, et al. Alzheimer’s disease: from pathogenesis to therapeutic implications [J]. Frontiers in Neuroscience, 2018, 12: 632.
[27] LI Lin, LI Wenjun, ZHENG Xiangru, et al. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation [J]. Molecular Medicine (Cambridge, Mass.), 2022, 28(1): 11.
[28] WU Tingyao, ZHAO Lingxiao, ZHANG Yanhui, et al. Activation of vitamin D receptor inhibits Tau phosphorylation is associated with reduction of iron accumulation in APP/PS1 transgenic mice [J]. Neurochemistry International, 2022, 153: 105260.
[29] PAN Yiming, ZHANG Yalin, LIU Ning, et al. Vitamin D attenuates Alzheimer-like pathology induced by okadaic acid[J]. ACS Chemical Neuroscience, 2021, 12(8): 1343-1350.
[30] ZAULKFFALI A S, MD RAZIP N N, SYED ALWI S S, et al. Vitamins D and E stimulate the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH neuronal cells[J]. Nutrients, 2019, 11(10): 2525.
[31] LIN C I, CHANG Yichen, KAO N J, et al. 1,25(OH)2D3 alleviates Aβ(25-35)-induced Tau hyperphosphorylation, excessive reactive Oxygen species, and apoptosis through interplay with glial cell line-derived neurotrophic factor signaling in SH-SY5Y cells[J]. International Journal of Molecular Sciences, 2020, 21(12): 4215.
[32] KHEIRI G, DOLATSHAHI M, RAHMANI F, et al. Role of p38/MAPKs in Alzheimer’s disease：implications for amyloid beta toxicity targeted therapy[J]. Reviews in the Neurosciences, 2018, 30(1): 9-30.
[33] SAAD EL-DIN S, RASHED L, MEDHAT E, et al. Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer’s disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways [J]. Steroids, 2020, 156: 108586.
[34] HOU Tingting, HAN Yundan, CONG Lin, et al. Apolipoprotein E facilitates amyloid-β oligomer-induced Tau phosphorylation[J]. Journal of Alzheimer’s Disease :JAD, 2020, 74(2): 521-534.
[35] GOMES L A, HIPP S A, RIJAL UPADHAYA A, et al. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein[J]. Acta Neuropathologica, 2019, 138(6): 913-941.
[36] KOUTSODENDRIS N, NELSON M R, RAO A, et al. Apolipoprotein E and Alzheimer’s disease: findings, hypotheses, and potential mechanisms[J]. Annual Review of Pathology, 2022, 17: 73-99.
[37] DAFNIS I, RAFTOPOULOU C, MOUNTAKI C, et al. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity[J]. The Biochemical Journal, 2018, 475(10):1839-1859.
[38] HUANG Y A, ZHOU Bo, WERNIG M, et al. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ secretion[J]. Cell, 2017, 168(3):427-441.e21.
?
相似文献/References:
[1]胡森安,艾红红,严丽花,等.维生素D及日照量对单纯性肥胖儿童血清瘦素水平影响的研究[J].现代检验医学杂志,2016,31(06):143.[doi:10.3969/j.issn.1671-7414.2016.06.043]
HU Sen-an,AI Hong-hong,YAN Li-hua,et al.Effect of Vitamin D and Sunlight on Serum Leptin Levels
in Simple Obese Children[J].Journal of Modern Laboratory Medicine,2016,31(03):143.[doi:10.3969/j.issn.1671-7414.2016.06.043]
[2]张宝华,武 琪.Nrf2基因启动子rs35652124,rs6706649和rs6721961位点单核苷酸多态性与阿尔茨海默病的相关性研究[J].现代检验医学杂志,2017,32(05):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
ZHANG Bao-hua,WU Qi.Association between Nrf2 Gene rs35652124,rs6706649
and rs6721961 Polymorphism and Alzheimer's Disease[J].Journal of Modern Laboratory Medicine,2017,32(03):62.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]孙祝平,陈红英,陈思路.老年阿尔茨海默病患者血清Lp-PLA2，NLRP3 水平表达及其与认知功能损害的相关性[J].现代检验医学杂志,2020,35(01):49.[doi:10.3969/j.issn.1671-7414.2020.01.013]
SUN Zhu-ping,CHEN Hong-ying,CHEN Si-lu.Expression of Serum Lp-PLA2 and NLRP3 in Elderly Patients with Alzheimer's
Disease and Its Relationship with Cognitive Impairment[J].Journal of Modern Laboratory Medicine,2020,35(03):49.[doi:10.3969/j.issn.1671-7414.2020.01.013]
[4]崔普芳,刘爱胜,李 喆,等.深圳龙华区孕妇血清维生素Ｄ水平及其受体基因rs2228570多态性与子痫前期易感性相关性研究[J].现代检验医学杂志,2021,36(05):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]
CUI Pu-fang,LIU Ai-sheng,LI Zhe,et al.Study on the Correlation between Serum Vitamin D Level and rs2228570Polymorphism of Its Receptor Gene and Preeclampsia Susceptibility inPregnant Women in Shenzhen Longhua District[J].Journal of Modern Laboratory Medicine,2021,36(03):23.[doi:10.3969/j.issn.1671-7414.2021.05.005]
[5]刘 浩,彭 勇,尹一帆,等.基于UPLC-MS/MS 建立早产儿血清25-(OH)D3 和3-epi-25-(OH)D3 检测新方法及临床初步应用[J].现代检验医学杂志,2023,38(03):170.[doi:10.3969/j.issn.1671-7414.2023.03.031]
LIU Hao,PENG Yong,YIN Yi-fan,et al.A Novel UPLC-MS/MS Method for Simultaneous Quantification of Serum 25- (OH)D3 and 3-epi-25(OH)D3 Followed by the Preliminary Application in Clinics[J].Journal of Modern Laboratory Medicine,2023,38(03):170.[doi:10.3969/j.issn.1671-7414.2023.03.031]
[6]李婷婷,陈 凤,刘 然.阿尔茨海默病患者血清FGF23 和ZAG 水平表达与认知功能的相关性分析[J].现代检验医学杂志,2023,38(06):166.[doi:10.3969/j.issn.1671-7414.2023.06.030]
LI Tingting,CHEN Feng,LIU Ran.Correlation Analysis between Serum FGF23 and ZAG Levels and Cognitive Function in Patients with Alzheimer’s Disease[J].Journal of Modern Laboratory Medicine,2023,38(03):166.[doi:10.3969/j.issn.1671-7414.2023.06.030]
[7]乔永峰,胡 健,马燕粉,等.陕西省汉中市1~6 岁儿童血清维生素D 水平调查及影响因素分析[J].现代检验医学杂志,2024,39(04):83.[doi:10.3969/j.issn.1671-7414.2024.04.015]
QIAO Yongfeng,HU Jian,MA Yanfen,et al.Investigation of Serum Vitamin D Levels and Analysis of Related Factors in Children Aged 1 ~ 6 in Hanzhong City of Shaanxi[J].Journal of Modern Laboratory Medicine,2024,39(03):83.[doi:10.3969/j.issn.1671-7414.2024.04.015]
[8]刘 倩,边 娜,孙旸园.阿尔茨海默病患者脑脊液SMOC1和OLFML3水平表达及对病情程度的评估价值[J].现代检验医学杂志,2024,39(06):124.[doi:10.3969/j.issn.1671-7414.2024.06.021]
LIU Qian,BIAN Na,SUN Yangyuan.Expression of SMOC1 and OLFML3 in Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Its Value in Evaluating the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2024,39(03):124.[doi:10.3969/j.issn.1671-7414.2024.06.021]
[9]高 硕,王培昌,侯玉丽.基于GEO数据库分析筛选小胶质细胞衰老与阿尔茨海默病相关的关键基因及潜在治疗药物[J].现代检验医学杂志,2025,40(06):7.[doi:10.3969/j.issn.1671-7414.2025.06.002]
GAO Shuo,WANG Peichang,HOU Yuli.Identification of Key Genes and Potential Therapeutic Drugs Associated with Microglial Senescence and Alzheimer’s Disease Based on GEO Database Analysis[J].Journal of Modern Laboratory Medicine,2025,40(03):7.[doi:10.3969/j.issn.1671-7414.2025.06.002]